ARAVIS VENTURES

aravis-ventures-logo

Aravis is the first independent Swiss on-shore private equity house, an established investor in the renewable energy and life science spaces. We are a "hands-on" investor taking leading positions and understanding the balance between finance, commercial assets and people. With this distinct and crafted approach, we are serving over 30 leading investors including corporates, pension funds, government funds, insurance companies and family offices. Currently actively managing more than a quarte... r of a billion Swiss francs, we have a cumulative history of investments in over 100 companies. These have resulted in several noticeable exits including the divestment of several renewable energy companies and a number of life science reverse take-overs, listings and trade sales. Our many years of experience in the Swiss fund industry have enabled us to establish a platform with a comprehensive offering of investment, accounting, regulatory and reporting expertise. Located in Zurich, Aravis was founded in 2001.

#SimilarOrganizations #People #Financial #More

ARAVIS VENTURES

Social Links:

Industry:
Biotechnology Energy Life Science Renewable Energy

Founded:
2001-01-01

Status:
Active

Contact:
+41 43 499 2000

Email Addresses:
[email protected]

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon WordPress Google Universal Analytics


Similar Organizations

not_available_image

AMS INDUSTRIES

AMS Industries was a private equity firm that used to invest in the energy and industrial sectors.

bioadvance-logo

BioAdvance

BioAdvance is a Pennsylvania-based venture capital firm that provides funding to life sciences startups.

korkia-logo

Korkia

Korkia is a private equity firm that makes investments in renewable energy and clean tech sectors.

quaker-bioventures-logo

Quaker BioVentures

Quaker BioVentures is a venture capital firm investing in life science companies. The firm leads investments across the spectrum of the


Current Advisors List

bernard-mach_image

Bernard Mach Chairman of the SAB @ Aravis Ventures
Board_member

richard-j-ulevitch_image

Richard J. Ulevitch Scientific Advisor @ Aravis Ventures
Advisor

Current Employees Featured

martin-meiler_image

Martin Meiler
Martin Meiler Partner @ Aravis Ventures
Partner

not_available_image

Stephan Schnรผrer
Stephan Schnรผrer Managing Partner @ Aravis Ventures
Managing Partner

marc-krattinger_image

Marc Krattinger
Marc Krattinger Partner @ Aravis Ventures
Partner

kadri-vunder_image

Kadri Vunder
Kadri Vunder Investment Manager @ Aravis Ventures
Investment Manager

andreas-jacobs_image

Andreas Jacobs
Andreas Jacobs Managing Partner & CFO @ Aravis Ventures
Managing Partner & CFO

raphael-lambin_image

Raphael Lambin
Raphael Lambin Associate @ Aravis Ventures
Associate

margaretha-bruelisauer_image

Margaretha Bruelisauer
Margaretha Bruelisauer Accountant @ Aravis Ventures
Accountant

oliver-thalmann_image

Oliver Thalmann
Oliver Thalmann Managing Partner @ Aravis Ventures
Managing Partner

thorsten-schulz_image

Thorsten Schulz
Thorsten Schulz Investment Manager @ Aravis Ventures
Investment Manager

evangeline-de-macedo_image

Evangeline de Macedo
Evangeline de Macedo PA to Chairman @ Aravis Ventures
PA to Chairman

Founder


jean-philippe-tripet_image

Jean-Philippe Tripet

simon-nebel_image

Simon Nebel

Investments List

Date Company Article Money raised
2014-03-27 Bird Rock Bio Aravis Ventures investment in Series B - Bird Rock Bio 15 M USD
2014-02-18 Synaffix BV Aravis Ventures investment in Series A - Synaffix BV N/A
2013-12-26 Bellerophon Therapeutics Aravis Ventures investment in Series A - Bellerophon Therapeutics 80 M USD
2013-12-02 Telormedix Aravis Ventures investment in Series B - Telormedix 6.16 M EUR
2012-01-25 Telormedix Aravis Ventures investment in Series B - Telormedix 6 M CHF
2010-10-12 Synosia Therapeutics Aravis Ventures investment in Series C - Synosia Therapeutics 30 M USD
2010-10-11 MerLion Pharma Aravis Ventures investment in Series C - MerLion Pharma 7 M USD
2009-12-11 Evolva Aravis Ventures investment in Post-IPO Equity - Evolva 27.5 M USD
2009-10-22 Evolva Aravis Ventures investment in Series B - Evolva 28 M CHF
2009-07-01 Symetis Aravis Ventures investment in Series B - Symetis 21.3 M USD

More informations about "Aravis Ventures" on Search Engine